Form 483

Tom Schantz Form 483, 2010-02-12

FDA issued a Form 483 to Tom Schantz on 2010-02-12 with 6 public-safe observations.

483· Form 483 issued6 observations

Tom Schantz · Castorland, United States · Issued February 12, 2010

Overview

  • 6 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Feb 2010
21 CFR 530.20(a)(2)(iv)

Tissue residue

Cited by Aldo J Milone, Arthur F Walker

12 Feb 2010
21 CFR 530.41(a)

Drugs prohibited for extralabel use in food producing animal

Cited by Aldo J Milone, Arthur F Walker

12 Feb 2010
FDCA 402(a)(4)

Drug inventory

Cited by Aldo J Milone, Arthur F Walker

12 Feb 2010
FDCA 402(a)(4)

Record keeping

Cited by Aldo J Milone, Arthur F Walker

12 Feb 2010
FDCA 501(a)(5)

Expired drugs

Cited by Aldo J Milone, Arthur F Walker

Inspected site

TSTom SchantzCastorland, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
FDCA 402(a)(4)Cited across public-safe Form 483 observations2x
FDCA 501(a)(5)Cited across public-safe Form 483 observations2x
21 CFR 530.20(a)(2)(iv)Cited across public-safe Form 483 observations1x
21 CFR 530.41(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere